The left atrial appendage (LAA) is the main source of thromboembolism in patients with non-
valvular atrial fibrillation (AF). As such, the LAA can be the target of specific occluding device …

Objectives This study aimed to investigate the feasibility and safety of left atrial appendage
occlusion (LAAO) procedures in patients with persistent left atrial appendage (LAA) …

Aims: The aim of our study was to evaluate the prevalence of left atrial cavity and
appendage thrombosis in patients undergoing cardioversion for non-valvular atrial …

Background and Objectives Oral delayed-release dimethyl fumarate (DMF) is not
recommended during pregnancy and should only be used if the potential benefit justifies the …

Intraprocedural stroke is a well-documented and feared potential risk of cardiovascular
transcatheter procedures (TPs). Moreover, subclinical neurological events or covert central …

Patients with atrial fibrillation (AF) suffer from a high risk of thrombosis. Currently, the
CHA2DS2-VASc score is the most widely used tool for risk stratification in patients with AF …

AF is the most common cardiac arrhythmia and has been identified as an independent risk
factor for stroke. The European Society of Cardiology guidelines recommend a …

Background Detection of left atrial appendage thrombus (LAAt) in acute stroke patients can
be improved by cardiac computed tomography using prospective electrocardiogram-gated …

Aims Blood stasis is the main cause of left atrial thrombosis (LAT) in atrial tachyarrhythmias.
The high-velocity flow inside the left atrium, due to mitral valve regurgitation, may prevent …

Atrial fibrillation (Afib) is the most common abnormal heart rhythm in adults and has become
a significant public health concern affecting 2% to 3% of the population in Europe and North …